Cardiac events recorders have been developed in order to record the heart rhythm during symptoms such as palpitations or presyncope, to first make a diagnosis, and subsequently drive the treatment strategy. In other circumstances, they can be also used in asymptomatic patients (to record silent atrial fibrillation for instance). Because they are non-invasive, potentially cost-saving and relatively easy to use, the external rhythm recording devices have shown some great advances in the last years, spreading from photoplethysmographic technique to real ECG reconstruction. Technological advances in the field of microelectronics, as well as in the field of data transmission have contributed to their widespread use in cardiology. The trend for miniaturization was also expanded to the implantable recorders. This paper will review will review advantages and limitations of the different existing available well-established recording devices, as well as the last technological developments in terms of ECG recordings.A 46 years old female, with chronic stage renal failure for 15 years, presents to the emergency room with a thrombosis of her brachiocephalic arteriovenous fistula (functional for 13 years). The cephalic vein was aneurismal (6cm diameter) and the brachial artery was not dilated. After proximal and distal control of the brachial artery and the proximal cephalic vein, the aneurismal arteriovenous fistula was excise, the cephalic vein was ligatured, and the brachial artery was repaired with an end to end anastomosis. Peripheral arterial disease of the lower extremities (PAD) is a serious condition, frequently under-evaluated. Long asymptomatic, it is easily detected by measuring the ankle-brachial index (ABI), a reference tool that is reliable, reproducible, simple and inexpensive. The objective of this thesis was to determine the rate of achievement of ABI in French Haute Autorité de santé indications, identify the associated factors and prioritize the obstacles to achieving ABI. Descriptive and analytical epidemiological study, with analysis of practices, prospectively addressed by postal questionnaire to a randomized sample of 220 general practitioners practicing in the European Metropolis of Lille between December 15, 2016 and February 15, 2017. Our sample consisted of 92 GPs (42% participation). Among them, only 6 practiced ABI, notably for intermittent claudication (n=5 5%, IC95% [1; 10]), the existence of at least 2 cardiovascular risk factors (n=2 2%, IC95% [0; 5]), diabetic patients over 40 years of age (n=2 2%, IC95% [0; 5]), patients with diabetes (n=2 2%, IC95% [0; 5]), patients with diabetes (n=2 1%, IC95% [0; 5]), patients with diabetes (n=2 1%, IC95% [0; 5]), and patients with diabetes (n=2 1%, IC95% [0; 5]) 2%, CI95% [0; 5]), patients over 50 years of age with a history of diabetes or smoking (n=2 2%, CI95% [0; 5]), or those with an unhealed lower extremity skin lesion (n=5 5%, CI95% [1; 10]). The most frequently cited barriers were the prescription of a routine echo-doppler (61%, 95% CI [51; 71]), lack of control (46%, 95% CI [36; 56]), time considered too long (17%, 95% CI [10; 25]), and equipment purchase or maintenance (19%, 95% CI [10.5; 26.4]). ABI is few used in our sample, mainly due to delegation to angiologists. ABI is few used in our sample, mainly due to delegation to angiologists. Complete atrioventricular block (AVB3) may be an urgent potentially lifethreatening situation. Our objective was to describe the routine management of AVB 3, with emphasis on the organizational aspects. From September 2019 to November 2019, a prospective national survey including 28 questions was electronically sent to 100 physicians (Google Form). The answers were collected from 93 physicians (response rate 93%). Permanent pacemaker implantation during weekends and nights (after 8PM) is possible for 49% of the operators (<5 times a year), for 15% (>5 times a year), impossible for 36% of the operators. For AVB3 nonresponsive to isoproterenol occurring during the night, a temporary pacing lead (TPL) is implanted by the on-site medical staff on-duty (27%), the on-call interventional cardiologist (21%), the on-call electrophysiologist (19%), a permanent pacemaker is implanted by the electrophysiologist (12%), the strategy is not standardized (15%). An externalized active fixation lead (AFL) for AVB3 has already been implanted by 50% of the operators. 80 (86%) have already observed a dislocation of the TPL, a cardiac perforation already occurred in 57 (61%), a groin hematoma in 35 (38%), and this technique was proscribed for 4% of the operators. Our survey shows important disparities in terms of management of AVB3 among the different centers. An externalized AFL with a reusable generator was used by half of the centers. Our survey shows important disparities in terms of management of AVB3 among the different centers. An externalized AFL with a reusable generator was used by half of the centers. In Tunisia, as elsewhere in the world, severe forms of acute respiratory distress syndrome (ARDS) related to SARS-Covid19 have been observed. When the usual means of resuscitation were no longer sufficient, the implementation of the Extracorporeal membrane oxygenation or ECMO was needed. The whole problem of the management of these patients in this pandemic period has been to manage the operation of the ECMO machine, usually reserved for expert and specialized centers in the field. The cardio-vascular surgery department of La Rabta teaching hospital of Tunis has tried the experience of management of ECMO implanted in the different reanimations of Tunis, remotely, using telemedicine and social networks. Thus, a Facebook-Messenger discussion group was created and enabled the management of patients under ECMO via video conferencing in real time involving all stakeholders. A call was made whenever the physician needed it. The video provided an opportunity to discuss with surgeons and perfusionists in real bring real added value.The coronavirus disease 2019 (COVID-19) outbreak has become a worldwide public health concern. https://www.selleckchem.com/products/elenestinib-phosphate.html Cardiovascular complications are relatively frequent, reaching 20% of COVID-19 patients and 43% of COVID-19 patients admitted in Intensive Care Unit. Cardiac injury mechanisms are multiple, including hyperinflammation, pro-coagulant and pro-thrombotic states, sepsis related cardiomyopathy, hypoxia in relation with lung severity, hemodynamic instability, cytokine storm, critically illness, direct myocardial insult by acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and stress cardiomyopathy. The authors report a narrative review about cardio-vascular complications and predictive factors of mortality in patients infected with COVID-19.